Lingwei Jin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Parathyroid Disorders and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Kruppel-like factors research 3
- Fibroblast Growth Factor Research 2
- Inflammasome and immune disorders 2
-
- Renal Diseases and Glomerulopathies 3
- Acute Kidney Injury Research 2
- Co-authors
- Zhihong Zhou (5 shared papers)Yan Chen (3 shared papers)Min Pan (7 shared papers)Jian Jin (1 shared paper)Yu Zheng (3 shared papers)Xiaoyan Xu (2 shared papers)Wenwen Huang (3 shared papers)Wei Cao (4 shared papers)
- Journals
- BMC Nephrology (2 papers)Nature Communications (1 paper)Antioxidants and Redox Signaling (1 paper)Disease Markers (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- China
In The Last Decade
Lingwei Jin
20 papers receiving 416 citations
Peers
Comparison fields: 5 of 81
- Nephrology 137
- Cancer Research 60
- Immunology 65
- Rheumatology 27
- Molecular Biology 131
Countries citing papers authored by Lingwei Jin
This map shows the geographic impact of Lingwei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingwei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingwei Jin more than expected).
Fields of papers citing papers by Lingwei Jin
This network shows the impact of papers produced by Lingwei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingwei Jin. The network helps show where Lingwei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingwei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 85 | |
| 2 | 2019 | 76 | |
| 3 | 2018 | 45 | |
| 4 | 2016 | 35 | |
| 5 | 2017 | 26 | |
| 6 | 2018 | 23 | |
| 7 | Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis. | 2018 | 19 |
| 8 | 2021 | 19 | |
| 9 | Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma. | 2015 | 17 |
| 10 | 2015 | 15 | |
| 11 | 2020 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2019 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2023 | 5 | |
| 16 | 2018 | 4 | |
| 17 | 2019 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2017 | 1 | |
| 20 | Decreased expression of miR-495 is associated with poor prognosis in clear cell renal cell carcinoma | 2017 | 1 |
About Lingwei Jin
Lingwei Jin is a scholar working on Molecular Biology, Nephrology, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 21 papers that have together received 417 indexed citations. Recurring topics across this work include Kruppel-like factors research (3 papers), Renal Diseases and Glomerulopathies (3 papers), Ferroptosis and cancer prognosis (2 papers), Fibroblast Growth Factor Research (2 papers), Systemic Lupus Erythematosus Research (2 papers), Inflammasome and immune disorders (2 papers), Phagocytosis and Immune Regulation (2 papers) and Acute Kidney Injury Research (2 papers). The work is most often cited by research in Nephrology (137 citations), Cancer Research (60 citations), Immunology (65 citations), Rheumatology (27 citations) and Molecular Biology (131 citations). Lingwei Jin has collaborated with scholars based in China. Frequent co-authors include Zhihong Zhou, Yan Chen, Min Pan, Jian Jin, Yu Zheng, Xiaoyan Xu, Wenwen Huang, Wei Cao, Li‐Ling Wu and Yu Zheng. Their work appears in journals such as BMC Nephrology, Nature Communications, Antioxidants and Redox Signaling, Disease Markers and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.